Back

Dual antiplatelet therapy after CABG: does ticagrelor plus aspirin improve graft patency enough to outweigh major bleeding? an updated systematic review and meta-analysis of 9,659 patients

30 August 2026 (17:15 - 18:05)
Organised by: Logo
Congress Presentation Part of: Heart transplantation: rationale for antiplatelet therapy post coronary artery bypass grafting surgery Coronary Arteries ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Cesar Arce

National Institute of Medical Sciences and Nutrition Salvador Zubiran, Mexico City (Mexico)

5 More presentations in this session

Presentation thumbnail
Everolimus-based immunosuppression in heart transplantation reduces cardiac allograft vasculopathy progression and preserves renal function: a systematic review and meta-analysis
Miss S. Vitte (Barretos, BR)
Abstract Slides Video
Presentation thumbnail
Bile acid profiles in heart transplant recipients and their association with acute cellular rejection
Ms K. Florek (Wroclaw, PL)
Abstract Slides Video
Presentation thumbnail
Intraoperative ticagrelor removal to reduce bleeding after urgent CABG: matched comparison of patient-level observational data
Professor U. Zeymer (Ludwigshafen, DE)
Abstract Slides Video
Presentation thumbnail
Prognostic value of the TRI-SCORE in concomitant surgery for secondary tricuspid regurgitation
Doctor R. Carvalheiro (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Left atrial functional remodeling after heart transplantation: longitudinal comparison of bicaval and biatrial techniques
Doctor A. Jomaa (Bad Oeynhausen, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Heart transplantation: rationale for antiplatelet therapy post coronary artery bypass grafting surgery

The Event

Event poster

ESC Congress 2026

30 August 2026 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Outcomes of dual antiplatelet therapy in combination with direct oral anticoagulants in patients with acute coronary syndrome: a meta-analysis
28 August 2022
thumbnail
Congress Presentation
The impact of ticagrelor therapy on CABG-related bleeding in patients with STEMI managed with pPCI
25 August 2023
thumbnail
Congress Presentation
Risk of myocardial infarction with coronary artery bypass grafting versus percutaneous coronary intervention: a systematic review and meta-analysis of fifteen randomised trials
2 September 2019
thumbnail
Congress Presentation
Perioperative risk and benefit of antiplatelet therapy in patients undergoing non-cardiac surgery within 1 year after percutaneous coronary intervention with second-generation drug-eluting stents.
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources